Motif ID: Tfap2b
Z-value: 0.821
Transcription factors associated with Tfap2b:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Tfap2b | ENSMUSG00000025927.7 | Tfap2b |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tfap2b | mm10_v2_chr1_+_19208914_19208967 | 0.24 | 4.7e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 8.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 2.2 | 2.2 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
| 1.6 | 4.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.3 | 4.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) negative regulation of dopaminergic neuron differentiation(GO:1904339) regulation of cardiac cell fate specification(GO:2000043) |
| 1.1 | 2.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.1 | 3.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.0 | 6.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.0 | 19.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 1.0 | 3.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
| 0.9 | 3.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.9 | 5.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.8 | 2.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.8 | 4.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.7 | 7.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.7 | 5.5 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.7 | 3.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.6 | 4.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.6 | 7.5 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 3.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.6 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 1.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.5 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 | 1.5 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
| 0.5 | 8.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.5 | 2.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.5 | 1.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.5 | 3.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.4 | 3.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.4 | 1.2 | GO:0040009 | nucleolus to nucleoplasm transport(GO:0032066) regulation of growth rate(GO:0040009) |
| 0.4 | 4.6 | GO:0030238 | male sex determination(GO:0030238) |
| 0.4 | 6.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.4 | 0.4 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.4 | 10.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.4 | 2.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.4 | 4.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.3 | 1.0 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) evasion or tolerance of host defenses by virus(GO:0019049) regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) positive regulation of mononuclear cell migration(GO:0071677) negative regulation of hyaluronan biosynthetic process(GO:1900126) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.3 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
| 0.3 | 2.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.3 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 1.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 3.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 1.2 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 1.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.2 | 0.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 | 1.1 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 2.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 2.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 3.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.2 | 2.7 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
| 0.2 | 7.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.2 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 3.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.2 | 0.7 | GO:0010756 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 0.5 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.2 | 1.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 9.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 | 1.2 | GO:0043586 | tongue development(GO:0043586) |
| 0.1 | 1.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.1 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 | 1.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.1 | 1.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 2.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 2.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 1.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 | 1.0 | GO:2000301 | myeloid progenitor cell differentiation(GO:0002318) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 1.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 2.4 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 2.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) megakaryocyte development(GO:0035855) |
| 0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 4.8 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.1 | 1.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 1.2 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.9 | GO:0070475 | nucleolus organization(GO:0007000) rRNA base methylation(GO:0070475) |
| 0.1 | 2.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 3.5 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 0.5 | GO:0048703 | embryonic neurocranium morphogenesis(GO:0048702) embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 2.6 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 0.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 0.2 | GO:0036166 | phenotypic switching(GO:0036166) |
| 0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 | 3.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 | 1.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.0 | 2.4 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.0 | 1.6 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.8 | GO:0030901 | midbrain development(GO:0030901) |
| 0.0 | 0.9 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
| 0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 1.7 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 1.7 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 | 1.7 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
| 0.0 | 3.5 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.0 | 1.2 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 4.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.9 | 4.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.6 | 2.6 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.5 | 5.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 2.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 1.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 3.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 2.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.2 | 3.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 3.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 8.8 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 3.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 1.1 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 3.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 3.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 1.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 9.7 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 4.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 7.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 3.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.0 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 1.1 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 1.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 2.4 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 6.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 5.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 2.9 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 3.3 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 3.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 3.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.9 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 5.6 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 2.0 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 0.0 | GO:0043220 | myelin sheath adaxonal region(GO:0035749) Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 4.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 1.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 1.3 | 4.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 1.2 | 4.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.0 | 7.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 1.0 | 12.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.8 | 3.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.8 | 3.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.5 | 1.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
| 0.5 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.5 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.5 | 5.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.5 | 1.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 7.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.4 | 3.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 7.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.4 | 4.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.3 | 7.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 6.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 2.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.2 | 5.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 1.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.2 | 1.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.2 | 4.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 3.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.2 | 3.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.2 | 1.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 1.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 2.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 2.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 2.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 2.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 8.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.6 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
| 0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 4.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.1 | 9.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 2.1 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.1 | 4.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 1.3 | GO:0008143 | poly(A) binding(GO:0008143) poly(U) RNA binding(GO:0008266) |
| 0.1 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 2.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 1.8 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
| 0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 3.2 | GO:0043851 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) selenocysteine methyltransferase activity(GO:0016205) rRNA (adenine) methyltransferase activity(GO:0016433) rRNA (cytosine) methyltransferase activity(GO:0016434) rRNA (guanine) methyltransferase activity(GO:0016435) 1-phenanthrol methyltransferase activity(GO:0018707) protein-arginine N5-methyltransferase activity(GO:0019702) dimethylarsinite methyltransferase activity(GO:0034541) 4,5-dihydroxybenzo(a)pyrene methyltransferase activity(GO:0034807) 1-hydroxypyrene methyltransferase activity(GO:0034931) 1-hydroxy-6-methoxypyrene methyltransferase activity(GO:0034933) demethylmenaquinone methyltransferase activity(GO:0043770) cobalt-precorrin-6B C5-methyltransferase activity(GO:0043776) cobalt-precorrin-7 C15-methyltransferase activity(GO:0043777) cobalt-precorrin-5B C1-methyltransferase activity(GO:0043780) cobalt-precorrin-3 C17-methyltransferase activity(GO:0043782) dimethylamine methyltransferase activity(GO:0043791) hydroxyneurosporene-O-methyltransferase activity(GO:0043803) tRNA (adenine-57, 58-N(1)-) methyltransferase activity(GO:0043827) methylamine-specific methylcobalamin:coenzyme M methyltransferase activity(GO:0043833) trimethylamine methyltransferase activity(GO:0043834) methanol-specific methylcobalamin:coenzyme M methyltransferase activity(GO:0043851) monomethylamine methyltransferase activity(GO:0043852) P-methyltransferase activity(GO:0051994) Se-methyltransferase activity(GO:0051995) 2-phytyl-1,4-naphthoquinone methyltransferase activity(GO:0052624) tRNA (uracil-2'-O-)-methyltransferase activity(GO:0052665) tRNA (cytosine-2'-O-)-methyltransferase activity(GO:0052666) phosphomethylethanolamine N-methyltransferase activity(GO:0052667) tRNA (cytosine-3-)-methyltransferase activity(GO:0052735) rRNA (cytosine-2'-O-)-methyltransferase activity(GO:0070677) rRNA (cytosine-N4-)-methyltransferase activity(GO:0071424) trihydroxyferuloyl spermidine O-methyltransferase activity(GO:0080012) |
| 0.0 | 0.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.0 | 2.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.0 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 3.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 1.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 1.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 1.7 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
| 0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 1.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.0 | 2.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.0 | 1.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.5 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
